Camp4 Therapeutics Files Q1 2025 10-Q
Ticker: CAMP · Form: 10-Q · Filed: May 13, 2025 · CIK: 1736730
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
Camp4 Therapeutics filed its Q1 2025 10-Q. Check financials.
AI Summary
Camp4 Therapeutics Corp filed a 10-Q for the period ending March 31, 2025. The company, located at One Kendall Square in Cambridge, MA, is in the pharmaceutical preparations industry. Key financial details and operational updates for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with the latest financial performance and operational status of Camp4 Therapeutics Corp for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Camp4 Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- Camp4 Therapeutics Corp (company) — Filer of the 10-Q
- One Kendall Square, Cambridge, MA (location) — Business and mailing address
- 20250331 (date) — Reporting period end date
- 20250513 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
What is Camp4 Therapeutics Corp's primary industry?
Camp4 Therapeutics Corp's primary industry is Pharmaceutical Preparations, with SIC code 2834.
Where is Camp4 Therapeutics Corp located?
Camp4 Therapeutics Corp is located at One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA 02139.
When was this 10-Q filed with the SEC?
This 10-Q was filed with the SEC on May 13, 2025.
What is the fiscal year end for Camp4 Therapeutics Corp?
The fiscal year end for Camp4 Therapeutics Corp is December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Camp4 Therapeutics Corp (CAMP).